H-1B sponsorship profile: Taiho Oncology, Inc. Across U.S. Department of Labor LCA disclosures, Taiho Oncology, Inc filed 8 Labor Condition Applications covering 8 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (8 certified of 8 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Taiho Oncology, Inc’s H-1B petitions range from $147,198 at the low end to $185,795 at the high end, with a petition-weighted average of $169,269. That range reflects the mix of occupations the company sponsors, led by Sr. Manager, Programming & DB Admin (1 petitions at $185,795 avg), followed by Sr. Manager, Pharmacovigilance Data Management & Processing and Sr. Analytical Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Taiho Oncology, Inc is headquartered in Princeton, NJ under NAICS code 541714, and places H-1B workers across 2 states, most heavily in CA, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Taiho Oncology, Inc ranks. By H-1B petition volume, Taiho Oncology, Inc is #19,368 of 119,880 employers nationally and #1,550 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.